Jacob Shore receives transfusions every two weeks and urges blood donations; his family hosts a blood drive at Center Global Methodist Church.
In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses treatment options for chronic kidney disease patients with ...
A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Bristol-Myers Squibb is ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...
Oct.1 marked the beginning of Breast Cancer Awareness Month, and the American Cancer Society (ACS) is commemorating 40 years of spreading awareness about the condition. Breast cancer is the second ...
(InvestigateTV) — A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis. In 2023, the FDA approved Lyfgenia, developed by ...
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry Germ cell tumors (GCTs) are a heterogeneous group of neoplasms that ...
Ayrmid Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback